BIBLIOGRAPHIC RECORD

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Megan J. Shram; Jack E. Henningfield; Glen Apseloff; Charles W. Gorodetzky; Sara De Martin; Frank L. Vocci; Frank L. Sapienza; Thomas R. Kosten; Jeff Huston; August Buchhalter; Judy Ashworth; Ryan K. Lanier; Franco B. Folli; Andrea Mattarei; Clotilde Guidetti; Stefano Comai; Cedric O’Gorman; Sergio Traversa; Charles E. Inturrisi; Paolo L. Manfredi; Marco Pappagallo
Source of metadata
OpenAlex
Year recorded
2023

Public identifiers and source

Open the source record

Reference

Megan J. Shram; Jack E. Henningfield; Glen Apseloff; Charles W. Gorodetzky; Sara De Martin; Frank L. Vocci; Frank L. Sapienza; Thomas R. Kosten; Jeff Huston; August Buchhalter; Judy Ashworth; Ryan K. Lanier; Franco B. Folli; Andrea Mattarei; Clotilde Guidetti; Stefano Comai; Cedric O’Gorman; Sergio Traversa; Charles E. Inturrisi; Paolo L. Manfredi; Marco Pappagallo. (2023). The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users. https://openalex.org/W4379768070

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-ef466db606b30aaea2255b55494756ba/